Photoreconversion of blowfly visual pigment proceeds through a slowly (13 ms) decaying intermediate

Summary The photochemical cycle of the visual pigment molecules in the blowflyCalliphora erythrocephala was investigated by transmission measurements, making use of the fact that intermediate states of the visual pigment molecules each have a characteristic absorption spectrum.It is shown that the conversion of metaxanthopsin (M 580) to the native xanthopsin state (P 490) induced by an orange-red light pulse proceeds through a newly discovered intermediate (N), which thermally decays with a time constant of about 13 ms at room temperature.The absorption spectrum of N peaks in the blue-green at about 490 nm. In the green and orange N absorbs more strongly than the native xanthopsin, but in the blue N and xanthopsin absorb almost equally. The latter finding explains why N has remained undetected in earlier studies.Abbreviations ERP early receptor potential - M metaxanthopsin - P xanthopsin     

Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer

The investigational drug flavone-8-acetic acid (FAA) potently augments NK activity in the spleen, liver, lungs, and peritoneum in a dose-dependent manner after i.v. or i.p. administration. Augmented NK activity peaks by 24 h after FAA injection and returns to normal after 6 days. Combined treatment of established murine renal cancer with FAA and rIL-2 results in up to 80% long term survival whereas FAA or rIL-2 alone were unable to induce any long term survivors. The optimal dose of rIL-2 required for use with FAA was in the range of 10,000 to 30,000 U/day. Further studies demonstrated that the regimen of FAA plus rIL-2 administration that was effective in treating established murine renal cancer also induced a more potent augmentation of NK activity than did either FAA or rIL-2 alone. Subsequent studies revealed that the therapeutic effectiveness of FAA plus rIL-2 was significantly reduced when tumor-bearing mice were treated with anti-asialo GM1 serum. These results are consistent with a role for augmented NK activity in the therapeutic effects of FAA plus rIL-2 murine renal cancer. In addition, these studies demonstrate that FAA and rIL-2 is a useful approach for cancer treatment in that subtoxic doses of rIL-2 can be used and significant anti-tumor efficacy occurs even without accompanying adoptive immunotherapy.